ADVANCED COLORECTAL ADENOCARCINOMA
Clinical trials for ADVANCED COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough colorectal cancer
Disease control TerminatedThis study tests the safety and effectiveness of combining the experimental drug AVUTOMETINIB (VS-6766) with cetuximab in people with advanced colorectal cancer that has a KRAS mutation. It is for those whose cancer worsened after prior treatments or who cannot tolerate them. The…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for tough colon cancer: Triple-Drug attack shows promise
Disease control OngoingThis study tests a combination of three drugs (botensilimab, balstilimab, and regorafenib) in people with a type of advanced colorectal cancer that is hard to treat (MSS type) and has worsened after standard chemotherapy. The goal is to see if this mix can shrink tumors or slow t…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC